Kezar Life Sciences’ Post

Real-world data reveals the frequency of administration-site reactions when treating hereditary angioedema attacks on-demand. Check out the report to learn more about the rates of these reactions and gain a better understanding of this treatment approach. #HereditaryAngioedema #TreatmentInsights

On World TB Day, we highlight the importance of effective diagnosis and treatment to combat this disease. Rifampicin is a cornerstone medication in TB treatment regimens. However, ensuring optimal drug levels is crucial to maximize treatment success and minimize the risk of drug resistance. This World TB Day,we emphasizes the importance of Rifampicin Therapeutic Drug Monitoring (TDM). TDM helps personalize treatment plans by measuring drug concentration in the bloodstream, ensuring effective levels to combat TB bacteria. We are committed to offering advanced diagnostic tools like Rifampicin TDM on Agilent Technologies to ensure optimal TB treatment outcomes. #WorldTBDay #TB #Rifampicin #TDM #TBFreeWorld #worldtbday

Defining a “clinically distinct” target population and addressing the limitations of trial evidence are just two of the challenges manufacturers face when trying to demonstrate the value of drugs for treating rare diseases. In our whitepaper the team explores seven key challenges in this area and offers approaches to help: https://buff.ly/3zFlD3i #LumanityPerspectives #HTA #HEOR #RareDiseases

By studying how the poxvirus family has produced both deadly diseases and historic cures, Dr. Zhilong Yang is developing new antiviral drugs for mpox and new methods for fighting future pandemics. Learn more about his team's research at https://lnkd.in/gdyZBCj9

Defining a “clinically distinct” target population and addressing the limitations of trial evidence are just two of the challenges manufacturers face when trying to demonstrate the value of drugs for treating rare diseases. In our whitepaper the team explores seven key challenges in this area and offers approaches to help: https://buff.ly/4ccLZXI #LumanityPerspectives #HTA #HEOR #RareDiseases

Our latest article highlights inequitable access to oral antivirals for treating COVID-19 in Aotearoa, both with respect to ethnicity and where people live. Find out more athttps://lnkd.in/gZPGfXyV

NSAID prescribing in high-risk groups is a major source of avoidable harm, study finds: https://lnkd.in/eJRz24P5

Are you developing drugs against respiratory diseases? Have you thought about how small airway epithelial cell (SAEC) model could help you obtain reliable drug toxicity and epithelial damage in vitro data to progress your drug?    Speak to our experts about how we can produce this data for you.  https://lnkd.in/d2Scd8ix #SAEC #epithelialdamage 

Are you developing drugs against respiratory diseases? Have you thought about how small airway epithelial cell (SAEC) model could help you obtain reliable drug toxicity and epithelial damage in vitro data to progress your drug?    Speak to our experts about how we can produce this data for you.  https://lnkd.in/d2Scd8ix #SAEC #epithelialdamage 

I receive this question a lot: Why would I want to screen for fentanyl rather than just an opioid screen?--------- Fentanyl is up to 100 times stronger than morphine and can be found in many illegal drugs, causing an unknown overdose situation. Fentanyl is so potent, that it may require extra doses of naloxone to treat the overdose. Trustworthy and targeted test results lead to better treatment outcomes. The ARK Fentanyl assay2 can be used on Siemens Healthineers chemistry systems including the Atellica® CH Analyzer. https://lnkd.in/gXkeViPA